DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qqj7fh/hematological) has announced the addition of the "Hematological Cancers Drug Pipeline Update 2013" report to their offering.
Unmet needs across the hematological malignancies remain high, with most traditional therapies conferring low levels of specificity and high toxicity.
There are today 412 companies plus partners developing 686 hematological cancer drugs in 1365 developmental projects in cancer. In addition, there are 8 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 206 drugs.
Hematological Cancers Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 352 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 336 out of the 341 studied drug targets so far have been recorded with somatic mutations. The software application lets you narrow in on these mutations and links out to the mutational analysis for each of the drug targets for detailed information. All drugs targets are further categorized on in the software application by 71 classifications of molecular function and with pathway referrals to BioCarta, KEGG, NCI-Nature and NetPath.
Drug Pipeline Update at a Glance
Investigators
Includes more than 412 principal companies plus their collaborators. There is direct access from inside the application to web pages of all principal companies.
Developmental stage
This Drug Pipeline Update contains 686 hematological cancer drugs in development, which have a total of 1365 developmental projects in cancer. In addition there are suspended and ceased drugs.
Indications
Included hematological cancer drugs are also in development for 253 other indications, where of 119 are different cancer indications.
For more information visit http://www.researchandmarkets.com/research/qqj7fh/hematological
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
